The Latest Breaking News from Obesity

Semaglutide, the drug behind the blockbuster weight-loss jabs Ozempic and Wegovy, does not slow cognitive decline in people with early-stage Alzheimer’s, according to two large new studies. The results close the door, for now, on hopes that a treatment for diabetes and obesity might also help protect the brain.

Social isolation kills. It increases your risk of death by 30% — roughly the same as smoking cigarettes and much worse than factors such as obesity and sedentary living.

Some recent national numbers suggest the obesity rate has plateaued or even declined. Experts are skeptical.

The global weight loss drug market, perhaps ironically, is growing like gangbusters these days. Globally, it’s set to expand from $15 billion in 2024 to $150 billion by 2035, according to Morgan Stanley.